Immune Checkpoint Inhibitor–Induced Seronegative Myasthenia-Like Syndrome Following Pembrolizumab Therapy: A Novel Adverse Drug Reaction
Immune checkpoint inhibitors (ICIs), including pembrolizumab, are increasingly associated with immune-related adverse events (irAEs), though neuromuscular complications remain rare. We report a distinctive case of pembrolizumab-induced seronegative myasthenia-like syndrome (ICI-MLS) in a 63-year-ol...
Kaydedildi:
| Asıl Yazarlar: | , |
|---|---|
| Materyal Türü: | Artigo |
| Dil: | Inglês |
| Baskı/Yayın Bilgisi: |
KARACHI MEDICAL AND DENTAL COLLEGE
2026-03-01
|
| Seri Bilgileri: | Annals of Abbasi Shaheed Hospital and Karachi Medical & Dental College |
| Konular: | |
| Online Erişim: | https://annals-ashkmdc.org/index.php/ashkmdc/article/view/1250 |
| Etiketler: |
Etiket eklenmemiş, İlk siz ekleyin!
|